1. Study to evaluate the role of TNFα, IL1β, IL6 in diagnosis and severity assessment of neonatal sepsis among term, appropriate for gestational age newborn
- Author
-
Avijit Hazra, Avranil Goswami, Moumita Samanta, Arijit Bhowmik, Somosri Ray, and Tapas K. Sabui
- Subjects
Pediatrics ,medicine.medical_specialty ,Appropriate for gestational age ,Neonatal sepsis ,business.industry ,Gynecology and obstetrics ,General Medicine ,medicine.disease ,RJ1-570 ,Term (time) ,Severity assessment ,RG1-991 ,Medicine ,Tumor necrosis factor alpha ,business - Abstract
Objective There is no established diagnostic test available to diagnose neonatal sepsis. Tumor necrosis factor a (TNFα), interleukin 1b (IL1β) and interleukin 6 (IL6) showed some promising results in some recent studies in this respect, but their roles in diagnosis and prognosis of neonatal sepsis are not yet conclusive. In this study, we have tried to identify diagnostic and prognostic ability of these biomarkers in neonatal sepsis. Methods In this cross-sectional study, blood sample for 3 cytokines were collected at diagnosis of neonatal sepsis fulfilling diagnostic criteria by purposive sampling and values were compared with normal healthy newborns. Each of the cytokines was evaluated separately to identify, whether they can detect neonatal sepsis with at least 70% sensitivity and specificity. At the same time, their prognostic values were also evaluated in terms of disease severity and mortality. Results Among twenty normal newborns, standard deviation values of TNFα, IL1β and IL6 were 39.7±21.5 pg/ml, 34.6±20.9 pg/ml and 44.4±33.0 pg/ml, respectively. In sepsis group (n=40), these values were 69.6±26.0 pg/ml, 57.7±29.0 pg/ml and 204.6±169.2 pg/ml, respectively. All these differences were statistically significant (p
- Published
- 2021
- Full Text
- View/download PDF